PATIENT'S FINGERS HURT; WHEN PATIENT GOT THE COVID VACCINATION, ARM HURT; COVID; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID), PAIN IN EXTREMITY (PATIENT'S FINGERS HURT) and VACCINATION SITE PAIN (WHEN PATIENT GOT THE COVID VACCINATION, ARM HURT) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect products included non-company products ADALIMUMAB (HUMIRA) solution for injection for Psoriatic arthritis and TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form, ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose and first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (Intramuscular) Dose 1 (1 in 1 Once). On an unknown date, received second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (Intramuscular) dosage was changed to Dose 2, (1 in 1 Once). In 2022, the patient experienced COVID-19 (COVID). On an unknown date, the patient experienced PAIN IN EXTREMITY (PATIENT'S FINGERS HURT) and VACCINATION SITE PAIN (WHEN PATIENT GOT THE COVID VACCINATION, ARM HURT). At the time of the report, COVID-19 (COVID) and VACCINATION SITE PAIN (WHEN PATIENT GOT THE COVID VACCINATION, ARM HURT) outcome was unknown and PAIN IN EXTREMITY (PATIENT'S FINGERS HURT) had not resolved.            No concomitant medications was reported. On unknown dates when patient got the covid vaccination, his arm hurt, and fingers hurt. He was not sure if the humira was working. In 2022, the patient experienced covid. Pfizer biontech covid-19 vaccine (tozinameran) and moderna covid-19 vaccine (elasomeran) were also considered suspect.   No treatment drug details was reported.  Company Comment: This is a spontaneous case concerning  a  68-year-old, female patient with no reported medical history, who experienced the unexpected non-serious events of Covid-19, Pain extremity, and expected non-serious event of Vaccination site pain. The exact date of administration of third dose of mRNA-1273 and onset of the events was not specified, hence latency could not be assessed. Other Co-suspect drugs are Adalimumab and Tozinameran which was given on an unknown date. No further details on clinical course, lab test results and treatment received were reported. Outcome of the events was not resolved at the time of report. The benefit-risk relationship of mRNA-1273 Vaccine, is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This is a spontaneous case concerning  a  68-year-old, female patient with no reported medical history, who experienced the unexpected non-serious events of Covid-19, Pain extremity, and expected non-serious event of Vaccination site pain.The exact date of administration of third dose of mRNA-1273 and onset of the events was not specified, hence latency could not be assessed. Other Co-suspect drugs are Adalimumab and Tozinameran which was given on an unknown date. No further details on clinical course, lab test results and treatment received were reported. Outcome of the events was not resolved at the time of report. The benefit-risk relationship of mRNA-1273 Vaccine, is not affected by this report.